ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi’s Dupixent 'rapidly' improves lung function in children pharmatimes
May 18, 2021Sanofi’s Dupixent significantly reduced severe asthma attacks and rapidly improved lung function in children aged six to 11 years old with uncontrolled moderate-to-severe asthma, according to detailed results from a Phase III trial.
Pharma Sources Insight January 2025
